Clinical Trial Detail

NCT ID NCT03289962
Title A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Genentech, Inc.

lung non-small cell carcinoma

cervical cancer

colorectal cancer

hepatocellular carcinoma

triple-receptor negative breast cancer

transitional cell carcinoma

skin squamous cell carcinoma

head and neck squamous cell carcinoma


anus cancer

Advanced Solid Tumor

Merkel cell carcinoma

renal cell carcinoma



Atezolizumab + RO7198457

Age Groups: adult senior

Additional content available in CKB BOOST